Sep 23, 2026 7 0
Uploaded by River Wang
Favorite
Share
More Options
12
A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer - the RibOB study_Page 1

Open in WPS to view all 12 pages